Action mechanism of tachyplesin I and effects of PEGylation |
| |
Authors: | Yuichi Imura Yoshiyuki Ogawa Katsumi Matsuzaki |
| |
Affiliation: | a Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan b Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan |
| |
Abstract: | PEGylation of protein and peptide drugs is frequently used to improve in vivo efficacy. We investigated the action mechanism of tachyplesin I, a membrane-acting cyclic antimicrobial peptide from Tachypleus tridentatus and the effects of PEGylation on the mechanism. The PEGylated peptide induced the leakage of calcein from egg yolk l-α-phosphatidylglycerol/egg yolk l-α-phosphatidylcholine large unilamellar vesicles similarly to the parent peptide. Both peptides induced lipid flip-flop coupled to leakage and was translocated into the inner leaflet of the bilayer, indicating that tachyplesin I forms a toroidal pore and that PEGylation did not alter the basic mechanism of membrane permeabilization of the parent peptide. Despite their similar activities against model membranes, the peptides showed very different biological activities. The cytotoxicity of tachyplesin I was greatly reduced by PEGylation, although the antimicrobial activity was significantly weakened. We investigated the enhancement of the permeability of inner membranes induced by the peptides. Our results suggested that outer membranes and peptidoglycan layers play an inhibitory role in the permeation of the PEG moiety. Furthermore, a reduction in DNA binding by PEGylation may also contribute to the weak activity of the PEGylated peptide. |
| |
Keywords: | AMEM, Alpha modification of Eagle's medium C6-NBD-PC, 1-palmitoyl-2-[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]caproyl]- smallcaps" >l-α-phosphatidylcholine CD, circular dichroism CFU, colony forming unit CHO, Chinese Hamster Ovary DNS-PE, N-(5-dimethylaminonaphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt FBS, fetal bovine serum Fmoc, 9-fluorenylmethoxycarbonyl HPLC, high-performance liquid chromatography L/P, lipid-to-peptide molar ratio LUVs, large unilamellar vesicles MIC, minimal inhibitory concentration MLVs, multilamellar vesicles NAPB, 10  mM sodium phosphate/100  mM NaCl, pH 7.4 buffer ONPG, o-nitrophenyl-β- smallcaps" >d-galactoside PC, egg yolk smallcaps" >l-α-phosphatidylcholine PEG, polyethyleneglycol PG, smallcaps" >l-α-phosphatidyl- smallcaps" >dl-glycerol enzymatically converted from PC Pyrene-PC, 1-hexadecanoyl-2-(1-pyrenehexanoyl)-sn-glycero-3-phosphocholine SUVs, small unilamellar vesicles TSB, tryptic soy broth WST-1, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt |
本文献已被 ScienceDirect 等数据库收录! |
|